Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC

Clinical trial NCT06177301 · RECRUITING

Trial details

NCT number: NCT06177301
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2023-12-01
Primary completion: 2026-12-01
Enrollment: 266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.